Pharmacokinetics in routine haemophilia clinical practice: rationale and modalities-a practical review

Therapeutic Advances in Hematology
Cedric Hermans, Gerry Dolan

Abstract

Prophylactic therapy with exogenous clotting factor concentrates in haemophilia A and B aims to achieve levels of circulating FVIII or FIX that are adequate for the prevention or reduction of spontaneous joint bleeding. Historically, a minimum trough level of at least 1% of the normal levels of circulating clotting factor has been targeted using standardised protocols. However, clearance of clotting factor varies between products and patients, and other pharmacokinetic (PK) parameters such as the frequency and magnitude of peaks may be important for ensuring optimal coverage. Thus, it is increasingly recognised that an individualised, PK-based approach to prophylaxis is necessary to achieve optimal protection. This review focuses on the clinical implications of using PK-guided, individualised prophylaxis in haemophilia to improve patient outcomes and considers practical methods of establishing patients' PK parameters. The most useful PK parameters will depend on the aim of the specific treatment (e.g. preventing activity-related and traumatic bleeds or addressing subclinical bleeding). In clinical practice, lengthy and frequent post-infusion sampling for PK analysis is costly and a significant burden for patients. However, a Ba...Continue Reading

References

Jun 1, 1987·British Journal of Haematology·D M SternP P Nawroth
Jul 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·D M SternJ Owen
Sep 5, 2002·British Journal of Clinical Pharmacology·Jaroslav ChládekMarie Noièková
Dec 1, 2004·Haemophilia : the Official Journal of the World Federation of Hemophilia·J AhnströmS Björkman
Aug 1, 2007·Journal of Thrombosis and Haemostasis : JTH·H M van den BergK Fischer
Jan 16, 2009·Journal of Thrombosis and Haemostasis : JTH·P W CollinsUNKNOWN rAHF-PFM Study Group
Oct 23, 2009·International Journal of Technology Assessment in Health Care·Aliasghar Ahmad Kia DaliriJahanara Mamikhani
Jun 29, 2010·Haemophilia : the Official Journal of the World Federation of Hemophilia·R WuJ Zhang
Aug 25, 2010·Haemophilia : the Official Journal of the World Federation of Hemophilia·P W CollinsUNKNOWN International Prophylaxis Study Group Pharmacokinetics Expert Working Group
Oct 31, 2012·Pediatric Blood & Cancer·Chris Barnes
Jan 3, 2013·Journal of Thrombosis and Haemostasis : JTH·S BjörkmanUNKNOWN Project on Factor VI I I/Factor IX Pharmacokinetics of the Factor VIII/Factor IX Scientific and Standardization Committee of
Mar 29, 2013·Haemophilia : the Official Journal of the World Federation of Hemophilia·C NegrierL Heijnen
May 7, 2013·Haematologica·Séverine HenrardCedric Hermans
Oct 12, 2013·Journal of Thrombosis and Haemostasis : JTH·D FengD W Stafford
Jan 26, 2016·Journal of Thrombosis and Haemostasis : JTH·A BrekkanS Jönsson
Mar 19, 2016·Haemophilia : the Official Journal of the World Federation of Hemophilia·M MorfiniG Tagariello
Apr 24, 2016·Blood·Brian CooleyDarrel W Stafford
Dec 16, 2016·JMIR Research Protocols·Alfonso IorioUNKNOWN WAPPS-Hemo co-investigator network
Mar 25, 2017·Journal of Clinical Medicine·Massimo Morfini
Mar 31, 2017·Thrombosis and Haemostasis·Alfonso IorioUNKNOWN Pharmacokinetic (PK) Expert Working Group of the International Prophylaxis Study Group (the IPSG)
Dec 10, 2017·Hematology·Alfonso Iorio
Mar 16, 2018·Haemophilia : the Official Journal of the World Federation of Hemophilia·Y DargaudP Mismetti
Jul 27, 2018·Research and Practice in Thrombosis and Haemostasis·Alfonso IorioJeffrey Spears
Mar 7, 2020·Haemophilia : the Official Journal of the World Federation of Hemophilia·Lynn M MalecRobert F Sidonio
Aug 4, 2020·Haemophilia : the Official Journal of the World Federation of Hemophilia·Alok SrivastavaUNKNOWN WFH Guidelines for the Management of Hemophilia panelists and co-authors

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging techniques

Software Mentioned

WAPPS
Hemo

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Haemophilia : the Official Journal of the World Federation of Hemophilia
Kun HuangRunhui Wu
Haemophilia : the Official Journal of the World Federation of Hemophilia
Yesim DargaudP Mismetti
Haemophilia : the Official Journal of the World Federation of Hemophilia
Peter W CollinsInternational Prophylaxis Study Group Pharmacokinetics Expert Working Group
© 2021 Meta ULC. All rights reserved